1. reformed4553
2. brianpitkin
3. edesedyjy69fed
4. mlaura
1.brianpitkin 01/26/2018
Company announced that new interim results from its ongoing Phase 1 clinical trial of MRG-106 in patients wi…
2.brianpitkin 02/05/2018
miRagen Therapeutics Announces Proposed Public Offering of Common Stock
3.reformed4553 02/05/2018
{Image}
4.edesedyjy69fed 02/05/2018
perfect day for it, everything is dying
5.edesedyjy69fed 02/02/2018
Nice News out - miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum
6.edesedyjy69fed 02/08/2018
Prices 7 mln share common stock offering at $5.50 per share
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW